United Therapeutics Slumps to 417th in Trading Volume Amid Earnings Anticipation and Sector Rotation

On October 6, 2025, United (UTHR) recorded a trading volume of $0.28 billion, a 22.7% decline from the previous day, ranking 417th in market activity. The stock closed with a 0.05% increase. Key developments influencing the stock include regulatory updates on therapeutic approvals and shifts in investor sentiment toward biotech sectors.

Analysts noted that United’s muted volume reflects cautious positioning ahead of upcoming earnings reports from peers. While the firm’s pipeline advancements in oncology therapies remain a long-term catalyst, short-term momentum appears constrained by broader market volatility in healthcare equities. Institutional holdings show a net outflow this week, suggesting rebalancing amid sector rotation.

To construct an accurate back-test I need a couple of details: 1. Stock universe • All U.S. common stocks? • A specific index (e.g., S&P 500 constituents)? • Another universe? 2. Entry/exit pricing • Buy at today’s close and sell at tomorrow’s close (standard for volume-rank studies)? • Buy at next day’s open and exit at that day’s close? • Something else? 3. Transaction costs or slippage assumptions (if any). Let me know your preferences and I’ll run the test from 2022-01-01 through today.